Albany Molecular Research, Inc. (AMRI) has made leadership changes following the restructuring of its large scale manufacturing facility in Rensselaer, NY. Steven R. Hagen, Ph.D. has been promoted to vice president for quality and analytical chemistry and Paul F. Vogt, Ph.D. has been promoted to director of manufacturing.

Dr. Hagen will be responsible for overseeing analytical and quality functions at all of AMRI’s facilities. He will also be responsible for the company’s regulatory activities, including the company’s relationship with the FDA. Dr. Hagen was previously senior director of analytical quality services, where he supervised the company’s analytical chemistry team, which measures the chemical purity and physical properties of drugs as they move through the drug development and manufacturing process. He joined the company in 2005 from his previous position as director of analytical R&D at Pfizer’s Global R&D Division in Kalamazoo, MI. He joined Pfizer in 1994 as a research scientist. Prior to Pfizer, he was an analytical biochemist with Ribi ImmunoChem Research, Inc.

In his new role, Dr. Vogt will be responsible for the manufacturing of all bulk chemicals, pharmaceuticals and intermediates at the company’s Rensselaer facility. He will oversee all compounds manufactured for human clinical trials and commercial products. Dr. Vogt joined the company in 1997 as a senior research chemist and has since held positions of increasing responsibility. He was promoted in 2005 to director of chemical development, where he oversaw the company’s chemical development activities, including managing customer projects and project teams involved in process research and scale-up activities.

“We are pleased to announce the promotions of Drs. Hagen and Vogt into these leadership roles at AMRI,” said AMRI chairman, chief executive officer and president Thomas E. D’Ambra, Ph.D. “These promotions occur as part of the restructuring of our large scale manufacturing operations. Steve and Paul each have managed areas of our business that have been bright spots performance-wise in the recent past. I am confident, as they bring their skills to their increased responsibilities, that AMRI has the right people in place to position our manufacturing operations for long-term growth and profitability. We are pleased to announce these changes and wish Steve and Paul continued career growth and success.”